Hybridon: Hybridon, Inc (Amex: HBY) was a biotechnology company based in Cambridge, Massachusetts, specializing in the discovery and development of novel therapeutics and diagnostics using synthetic DNA, that merged with Idera Pharmaceuticals in 2004.
No comments:
Post a Comment